Status:

TERMINATED

nContactSurgical Numeris-AF Tethered Coagulation System for Treatment of Persistent & LSP AF

Lead Sponsor:

nContact Surgical Inc.

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

This is a multi center, non-randomized, prospective, open label, clinical trial evaluating the safety and efficacy of the nContact Surgical Numeris-AF Tethered Coagulation System when used to treat pa...

Detailed Description

The purpose of this study is to determine the safety and efficacy of the Numeris-AF Tethered Coagulation System with VisiTrax when used to treat persistent and longstanding persistent Atrial Fibrillat...

Eligibility Criteria

Inclusion

  • Age \> 18 years; \< 80 years
  • Left atrium =\< 6.0 cm
  • Documented persistent or longstanding persistent AF
  • History of AF =\< 10 years
  • Scheduled for a concomitant cardiac procedure
  • Coronary bypass surgery (CABG)
  • Mitral valve repair/replacement
  • Aortic valve replacement
  • ASD repair
  • Tricuspid valve repair/replacement
  • Myxoma
  • Any combination of the above procedures
  • Provided written informed consent

Exclusion

  • Left atrial size \> 6.0 cm (pre-op TTE - parasternal 4 chamber view)
  • History of AF \> 10 years
  • Left ventricular ejection fraction \< 30%
  • Pregnant or planning to become pregnant during study
  • Co-morbid medical conditions that limit one year life expectancy
  • History of coagulopathy
  • Patients who are contraindicated for anticoagulants(heparin, warfarin etc.)
  • Previous cardiac surgery
  • History of pericarditis
  • Previous cerebrovascular accident (CVA)
  • Patients who have active infection or sepsis
  • Patients who have uncorrected reversible cause(s) of AF such as hyperthyroidism and electrolyte imbalance
  • Patients who are being treated for ventricular arrhythmias
  • Patients who have had a previous catheter ablation for AF (does not include ablation for Aflutter)
  • Current participation in another clinical investigation of a medical device or a drug, or recent participation in such a study within 30 days prior to study enrollment.
  • Not competent to legally represent him or herself (e.g., requires a guardian or caretaker as a legal representative).

Key Trial Info

Start Date :

October 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2013

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT00950092

Start Date

October 1 2009

End Date

October 1 2013

Last Update

April 3 2014

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Venice Regional Medical Center

Venice, Florida, United States, 34285-3298

2

Baptist Memorial Hospital

Memphis, Tennessee, United States, 38120

nContactSurgical Numeris-AF Tethered Coagulation System for Treatment of Persistent & LSP AF | DecenTrialz